{"filing":{"accession_number":"0001104659-26-077820","cik":"0001819411","ticker":"GANX","company_name":"Gain Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"tm2618851d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926077820/tm2618851d1_8k.htm"},"events":[{"id":13993,"run_id":12443,"accession_number":"0001104659-26-077820","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the final voting results from Gain Therapeutics' June 24, 2026 annual meeting of stockholders, including the election of seven directors and ratification of Ernst \u0026 Young AG as independent auditor. The detailed vote tallies for each nominee and the auditor ratification proposal are the core content, matching the shareholder_vote_results event type precisely.","company_name":"Gain Therapeutics, Inc.","ticker":"GANX","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":11299,"accession_number":"0001104659-26-077820","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the final voting results from Gain Therapeutics' June 24, 2026 annual meeting of stockholders, including the election of seven directors and ratification of Ernst \u0026 Young AG as independent auditor. The detailed vote tallies for each nominee and the auditor ratification proposal are the core content, matching the shareholder_vote_results event type precisely.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T21:03:43.487069+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11299,"accession_number":"0001104659-26-077820","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the final voting results from Gain Therapeutics' June 24, 2026 annual meeting of stockholders, including the election of seven directors and ratification of Ernst \u0026 Young AG as independent auditor. The detailed vote tallies for each nominee and the auditor ratification proposal are the core content, matching the shareholder_vote_results event type precisely.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T21:03:43.487069+00:00","company_name":"Gain Therapeutics, Inc.","ticker":"GANX","filing_date":"2026-06-25"}]}